Group One Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,641
| Closed | -$446K | – | 7679 |
|
|
2025
Q4 | $454K | Buy |
7,641
+2,606
| +52% | +$142K | ﹤0.01% | 3623 |
|
|
2025
Q3 | $273K | Sell |
5,035
-84,940
| -94% | -$4.86M | ﹤0.01% | 4330 |
|
|
2025
Q2 | $4.95M | Sell |
89,975
-13,982
| -13% | -$823K | 0.01% | 1337 |
|
|
2025
Q1 | $7.35M | Sell |
103,957
-22,665
| -18% | -$1.52M | 0.02% | 798 |
|
|
2024
Q4 | $8.32M | Buy |
126,622
+68,474
| +118% | +$4.59M | 0.02% | 819 |
|
|
2024
Q3 | $4.09M | Buy |
58,148
+22,576
| +63% | +$1.89M | 0.01% | 1155 |
|
|
2024
Q2 | $2.93M | Buy |
35,572
+15,329
| +76% | +$1.28M | 0.01% | 1157 |
|
|
2024
Q1 | $1.77M | Buy |
+20,243
| New | +$1.81M | 0.01% | 1583 |
|
|
2023
Q4 | – | Sell |
-8,073
| Closed | -$714K | – | 7405 |
|
|
2023
Q3 | $714K | Sell |
8,073
-50,188
| -86% | -$4.47M | ﹤0.01% | 2582 |
|
|
2023
Q2 | $5.05M | Buy |
+58,261
| New | +$5.48M | 0.02% | 949 |
|
|
2023
Q1 | – | Sell |
-17,361
| Closed | -$1.8M | – | 7223 |
|
|
2022
Q4 | $1.8M | Sell |
17,361
-21,547
| -55% | -$2.02M | ﹤0.01% | 1916 |
|
|
2022
Q3 | $3.3M | Sell |
38,908
-23,889
| -38% | -$2.13M | 0.01% | 1502 |
|
|
2022
Q2 | $5.2M | Buy |
62,797
+20,814
| +50% | +$1.66M | 0.01% | 1264 |
|
|
2022
Q1 | $3.24M | Sell |
41,983
-11,299
| -21% | -$945K | ﹤0.01% | 1911 |
|
|
2021
Q4 | $4.71M | Buy |
53,282
+9,578
| +22% | +$790K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $3.38M | Sell |
43,704
-7,582
| -15% | -$598K | ﹤0.01% | 2113 |
|
|
2021
Q2 | $4.28M | Sell |
51,286
-36,145
| -41% | -$2.87M | 0.01% | 1844 |
|
|
2021
Q1 | $6.6M | Sell |
87,431
-54,827
| -39% | -$4.48M | 0.01% | 1278 |
|
|
2020
Q4 | $12.5M | Buy |
142,258
+59,676
| +72% | +$4.73M | 0.02% | 685 |
|
|
2020
Q3 | $6.28M | Buy |
+82,582
| New | +$8.36M | 0.02% | 769 |
|
|
2020
Q1 | – | Sell |
-8,784
| Closed | -$757K | – | 5263 |
|
|
2019
Q4 | $743K | Sell |
8,784
-59,210
| -87% | -$4.47M | 0.01% | 2124 |
|
|
2019
Q3 | $4.58M | Buy |
67,994
+58,146
| +590% | +$4.48M | 0.04% | 627 |
|
|
2019
Q2 | $843K | Buy |
+9,848
| New | +$842K | 0.01% | 1713 |
|
|
2019
Q1 | – | Sell |
-33,858
| Closed | -$3.14M | – | 4812 |
|
|
2018
Q4 | $2.88M | Sell |
33,858
-3,333
| -9% | -$317K | 0.03% | 787 |
|
|
2018
Q3 | $3.61M | Buy |
37,191
+8,207
| +28% | +$819K | 0.03% | 766 |
|
|
2018
Q2 | $2.73M | Buy |
28,984
+11,584
| +67% | +$1.01M | 0.02% | 902 |
|
|
2018
Q1 | $1.41M | Sell |
17,400
-99,877
| -85% | -$8.57M | 0.01% | 1246 |
|
|
2017
Q4 | $10.5M | Buy |
117,277
+101,704
| +653% | +$8.84M | 0.07% | 325 |
|
|
2017
Q3 | $1.45M | Buy |
15,573
+12,890
| +480% | +$1.14M | 0.01% | 1292 |
|
|
2017
Q2 | $244K | Sell |
2,683
-20,913
| -89% | -$1.9M | ﹤0.01% | 2498 |
|
|
2017
Q1 | $2.07M | Sell |
23,596
-77,621
| -77% | -$6.91M | 0.02% | 843 |
|
|
2016
Q4 | $8.38M | Sell |
101,217
-3,437
| -3% | -$296K | 0.08% | 274 |
|
|
2016
Q3 | $9.68M | Buy |
104,654
+53,107
| +103% | +$5M | 0.11% | 194 |
|
|
2016
Q2 | $4.01M | Sell |
51,547
-1,966
| -4% | -$167K | 0.05% | 471 |
|
|
2016
Q1 | $4.41M | Buy |
53,513
+15,098
| +39% | +$1.23M | 0.06% | 388 |
|
|
2015
Q4 | $4.02M | Sell |
38,415
-26,108
| -40% | -$2.73M | 0.05% | 466 |
|
|
2015
Q3 | $6.8M | Buy |
64,523
+28,462
| +79% | +$3.8M | 0.09% | 249 |
|
|
2015
Q2 | $4.93M | Sell |
36,061
-12,158
| -25% | -$1.51M | 0.07% | 337 |
|
|
2015
Q1 | $6.01M | Buy |
+48,219
| New | +$5.11M | 0.09% | 202 |
|
|
2014
Q4 | – | Sell |
-4,819
| Closed | -$401K | – | 4897 |
|
|
2014
Q3 | $348K | Sell |
4,819
-42,152
| -90% | -$2.77M | 0.01% | 1899 |
|
|
2014
Q2 | $2.92M | Buy |
+46,971
| New | +$2.84M | 0.05% | 512 |
|
|
2014
Q1 | – | Sell |
-11,439
| Closed | -$843K | – | 5186 |
|
|
2013
Q4 | $804K | Sell |
11,439
-3,511
| -23% | -$238K | 0.01% | 1259 |
|
|
2013
Q3 | $1.08M | Buy |
+14,950
| New | +$994K | 0.02% | 956 |
|
Other funds holding BMRN
VPC
Group One Trading's BMRN Position: Q1 2026 in Review
Group One Trading sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 7,641 shares — an estimated $446K sold.
Group One Trading first reported a position in BMRN in Q3 2013 and held it in 43 quarters. The position peaked at $12.5M in Q4 2020. 559 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Group One Trading reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 7,641 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $446K.
- Group One Trading first reported a position in BioMarin Pharmaceuticals in Q3 2013 and held it in 43 quarters.
- Group One Trading's BioMarin Pharmaceuticals position peaked at $12.5M in Q4 2020.
- 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.